155 related articles for article (PubMed ID: 26887740)
1. Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
Seftel AD
J Urol; 2016 Mar; 195(3):713. PubMed ID: 26887740
[No Abstract] [Full Text] [Related]
2. Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
Penson DF
J Urol; 2015 Dec; 194(6):1710-1. PubMed ID: 26582698
[No Abstract] [Full Text] [Related]
3. Words of Wisdom. Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
Tasian GE; Cooperberg MR
Eur Urol; 2016 Feb; 69(2):374-5. PubMed ID: 26758522
[No Abstract] [Full Text] [Related]
4. Words of Wisdom. RE: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
Damber JE
Eur Urol; 2015 Dec; 68(6):1102. PubMed ID: 26545574
[No Abstract] [Full Text] [Related]
5. Sexual dysfunction: PDE5i and melanoma-correlation is not causation.
Stone L
Nat Rev Urol; 2015 Aug; 12(8):418. PubMed ID: 26171805
[No Abstract] [Full Text] [Related]
6. Sildenafil may elevate melanoma risk.
Grichnik JM
Dermatol Ther; 2014; 27(5):313. PubMed ID: 25285874
[No Abstract] [Full Text] [Related]
7. Role of sildenafil in melanoma incidence and mortality.
Robinson JK
JAMA Intern Med; 2014 Jun; 174(6):970-1. PubMed ID: 24710720
[No Abstract] [Full Text] [Related]
8. Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
Loeb S; Folkvaljon Y; Lambe M; Robinson D; Garmo H; Ingvar C; Stattin P
JAMA; 2015 Jun 23-30; 313(24):2449-55. PubMed ID: 26103029
[TBL] [Abstract][Full Text] [Related]
9. [Erectile dysfunction, PDE5A inhibitors and melanoma].
Schmutz JL
Ann Dermatol Venereol; 2015 Dec; 142(12):800-1. PubMed ID: 26293983
[No Abstract] [Full Text] [Related]
10. Erectile Dysfunction Medications and Skin Cancer: An Analysis in US Veterans.
Christie A; Vera PL; Higgins M; Kumar S; Lane M; Preston D
Urology; 2019 Apr; 126():116-120. PubMed ID: 30735744
[TBL] [Abstract][Full Text] [Related]
11. Association between phosphodiesterase type 5 inhibitors use and risk of melanoma: a meta-analysis.
Deng T; Duan X; Liu B; Lan Y; Cai C; Zhang T; Zhu W; Mai Z; Wu W; Zeng G
Neoplasma; 2018; 65(2):216-221. PubMed ID: 29534582
[TBL] [Abstract][Full Text] [Related]
12. Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma: D. F. Penson J Urol 2015;194:1710-1711.
Loeb S; Lambe M; Stattin P
J Urol; 2016 Apr; 195(4 Pt 1):1172-3. PubMed ID: 26783933
[No Abstract] [Full Text] [Related]
13. Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer.
Lian Y; Yin H; Pollak MN; Carrier S; Platt RW; Suissa S; Azoulay L
Eur Urol; 2016 Nov; 70(5):808-815. PubMed ID: 27178449
[TBL] [Abstract][Full Text] [Related]
14. Melanoma, Viagra, and PDE5 Inhibitors: Proliferation and Metastasis.
Houslay MD
Trends Cancer; 2016 Apr; 2(4):163-165. PubMed ID: 28741569
[TBL] [Abstract][Full Text] [Related]
15. [Sildenafil and increase in melanoma risk].
Saillen E
Rev Med Suisse; 2014 Jun; 10(433):1268-9. PubMed ID: 25004777
[No Abstract] [Full Text] [Related]
16. Phosphodiesterase type 5 inhibitors and risk of melanoma: A meta-analysis.
Tang H; Wu W; Fu S; Zhai S; Song Y; Han J
J Am Acad Dermatol; 2017 Sep; 77(3):480-488.e9. PubMed ID: 28728871
[TBL] [Abstract][Full Text] [Related]
17. [Current role of sildenafil in the management of erectile dysfunction].
Akhvlediani ND; Matyukhov IP
Urologiia; 2018 May; (2):142-146. PubMed ID: 29901310
[TBL] [Abstract][Full Text] [Related]
18. Are Erectile Dysfunction Medications Causally Related to Nonarteritic Anterior Ischemic Optic Neuropathy?
Lee MS; Vaphiades M
J Neuroophthalmol; 2016 Jun; 36(2):202-7. PubMed ID: 26828844
[No Abstract] [Full Text] [Related]
19. Nonarteritic Anterior Ischemic Optic Neuropathy and Erectile Dysfunction Drugs: Is There an Elephant in the Bedroom?
Kruger JM; Pomeranz HD
J Neuroophthalmol; 2017 Mar; 37(1):104-105. PubMed ID: 27984350
[No Abstract] [Full Text] [Related]
20. PDE5 inhibitors for erectile dysfunction revisited.
Med Lett Drugs Ther; 2012 Feb; 54(1383):10-1. PubMed ID: 22354220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
